Law Firm Brower Piven Announces Investigation in Connection With the Acquisition of PSS World Medical, Inc. by McKesson
STEVENSON, Md.--(BUSINESS WIRE)-- The law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of PSS World Medical, Inc. ("PSS World Medical") (NAS: PSSI) and other violations of state law by the board of directors of PSS World Medical relating to the proposed acquisition of the company by McKesson Corporation ("McKesson"). The firm's investigation seeks to determine, among other things, whether the board breached their fiduciary duties by failing to maximize shareholder value.
On October 25, 2012, PSS World Medical and McKesson announced that they have entered into a definitive agreement providing for McKesson to acquire PSS World Medical for $2.1 billion (including the assumption of debt). Under the terms of the merger agreement, PSS World Medical shareholders will receive $29.00 per share in cash.
If you currently own shares of PSS World Medical and would like to learn more about the investigation being conducted by Brower Piven, you may email or call Brower Piven, who will, without obligation or cost to you, attempt to answer your questions. You may contact Brower Piven by email at email@example.com, by calling (410) 415-6616, or at Brower Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven have combined experience litigating securities and other class action cases of over 60 years.
Brower Piven, A Professional Corporation
Charles J. Piven, 410-415-6616
KEYWORDS: United States North America Maryland
The article Law Firm Brower Piven Announces Investigation in Connection With the Acquisition of PSS World Medical, Inc. by McKesson originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.